AIM ImmunoTech Financials
| 0A4Y Stock | 0.14 0.02 16.67% |
AIM | Select Account or Indicator |
Understanding current and past AIM ImmunoTech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AIM ImmunoTech's financial statements are interrelated, with each one affecting the others. For example, an increase in AIM ImmunoTech's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in AIM ImmunoTech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AIM ImmunoTech. Check AIM ImmunoTech's Beneish M Score to see the likelihood of AIM ImmunoTech's management manipulating its earnings.
AIM ImmunoTech Stock Summary
AIM ImmunoTech competes with Eastinco Mining, Atalaya Mining, AMG Advanced, AfriTin Mining, and Advanced Medical. AIM ImmunoTech is entity of United Kingdom. It is traded as Stock on LSE exchange.Specialization | Energy, Energy |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| Business Address | 2117 SW Highway |
| Sector | Oil, Gas & Consumable Fuels |
| Industry | Energy |
| Benchmark | Dow Jones Industrial |
| Website | aimimmuno.com |
| Phone | 352 448 7797 |
You should never invest in AIM ImmunoTech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AIM Stock, because this is throwing your money away. Analyzing the key information contained in AIM ImmunoTech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
AIM ImmunoTech Key Financial Ratios
There are many critical financial ratios that AIM ImmunoTech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that AIM ImmunoTech reports annually and quarterly.| Revenue | 190 K | ||||
| Gross Profit | 154 K | ||||
| Net Income | (19.45 M) | ||||
| Retained Earnings | (361.1 M) |
AIM ImmunoTech Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Retained Earnings | (318.6M) | (327.6M) | (342.0M) | (361.1M) | (325.0M) | (341.2M) | |
| Other Assets | 1.4M | 1.9M | 748K | 1.3M | 1.2M | 1.1M | |
| Total Current Assets | 3.8M | 10.4M | 40.3M | 50.2M | 57.7M | 60.6M | |
| Common Stock | 1K | 10K | 42K | 48K | 55.2K | 29.0K | |
| Other Liab | 1.1M | 57K | 180K | 35K | 31.5K | 29.9K | |
| Net Tangible Assets | 4.3M | 11.5M | 59.1M | 54.2M | 62.3M | 65.4M | |
| Accounts Payable | 680K | 472K | 383K | 198K | 178.2K | 169.3K | |
| Net Receivables | 1.1M | 820K | 1.1M | 1.6M | 1.9M | 1.0M |
AIM ImmunoTech Key Income Statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Net Income Applicable To Common Shares | (9.8M) | (9.4M) | (14.4M) | (19.1M) | (17.2M) | (18.1M) | |
| Ebit | (11.5M) | (12.4M) | (14.9M) | (17.1M) | (15.4M) | (16.1M) |
AIM ImmunoTech Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (1.1M) | 1.2M | 37.0M | (6.4M) | (7.4M) | (7.0M) | |
| Depreciation | 837K | 792K | 733K | 775K | 697.5K | 701.3K | |
| Net Income | (9.5M) | (14.4M) | (19.1M) | (19.4M) | (17.5M) | (18.4M) | |
| Investments | (831K) | (5.8M) | (8.6M) | (243K) | (218.7K) | (229.6K) | |
| Net Borrowings | 4.9M | 1.1M | (4.7M) | (4.9M) | (4.4M) | (4.2M) | |
| Change To Netincome | 164K | (200K) | 2.6M | 3.4M | 4.0M | 4.2M |
AIM Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AIM ImmunoTech's current stock value. Our valuation model uses many indicators to compare AIM ImmunoTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AIM ImmunoTech competition to find correlations between indicators driving AIM ImmunoTech's intrinsic value. More Info.AIM ImmunoTech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AIM ImmunoTech's earnings, one of the primary drivers of an investment's value.AIM ImmunoTech Systematic Risk
AIM ImmunoTech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AIM ImmunoTech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on AIM ImmunoTech correlated with the market. If Beta is less than 0 AIM ImmunoTech generally moves in the opposite direction as compared to the market. If AIM ImmunoTech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AIM ImmunoTech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AIM ImmunoTech is generally in the same direction as the market. If Beta > 1 AIM ImmunoTech moves generally in the same direction as, but more than the movement of the benchmark.
AIM ImmunoTech Total Assets Over Time
AIM ImmunoTech Thematic Clasifications
AIM ImmunoTech is part of IT investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains
This theme covers Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains. Get More Thematic Ideas
| IT | View |
AIM ImmunoTech February 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AIM ImmunoTech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AIM ImmunoTech. We use our internally-developed statistical techniques to arrive at the intrinsic value of AIM ImmunoTech based on widely used predictive technical indicators. In general, we focus on analyzing AIM Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AIM ImmunoTech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 46.32 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 9.52 |
Additional Tools for AIM Stock Analysis
When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.